APA (7th ed.) Citation

NZH, W., DWT, Y., RJM, O., JJ, Z., YH, C., JCS, T., . . . SS, D. (2023). Efficacy of Oral SERDs in the treatment of ER+, HER2 - metastatic breast cancer, a stratified analysis of the ESR1 wild type and mutant subgroups. Annals of oncology : official journal of the European Society for Medical Oncology. https://doi.org/10.1016/j.annonc.2023.10.122

Chicago Style (17th ed.) Citation

NZH, Wong, Yap DWT, Ong RJM, Zhao JJ, Chan YH, Tey JCS, Sundar R, Lim JSJ, and Dawood SS. "Efficacy of Oral SERDs in the Treatment of ER+, HER2 - Metastatic Breast Cancer, a Stratified Analysis of the ESR1 Wild Type and Mutant Subgroups." Annals of Oncology : Official Journal of the European Society for Medical Oncology 2023. https://doi.org/10.1016/j.annonc.2023.10.122.

MLA (9th ed.) Citation

NZH, Wong, et al. "Efficacy of Oral SERDs in the Treatment of ER+, HER2 - Metastatic Breast Cancer, a Stratified Analysis of the ESR1 Wild Type and Mutant Subgroups." Annals of Oncology : Official Journal of the European Society for Medical Oncology, 2023, https://doi.org/10.1016/j.annonc.2023.10.122.